Sector dividends IRLAB Therapeutics AB

Stocks

Delayed Nasdaq Stockholm 15:03:25 25/08/2026 +04			5-day change	1st Jan Change
1.740 ^SEK	+0.35%		0.00%	-11.68%

08-19	Irlab's IRL757 is assigned the name linepemat by WHO	FW
08-19	IRLAB Therapeutics AB's Drug Candidate IRL757 Receives Generic Name Linepemat From WHO And Provides Update On Clinical Development	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Dividend Yield (Y)	Dividend Yield (Y+1)	P/E (Y)	Price to Book (Y)	EV / Sales (Y)	EV / EBITDA (Y)	EV / EBIT (Y)	Capi.($)
IRLAB THERAPEUTICS AB	-	-	-	-	-	-	-	27.18M
ELI LILLY AND COMPANY	0.56%	0.62%	35.49x	22.52x	12.87x	26.08x	27.64x	1,111B
JOHNSON & JOHNSON	1.97%	2.06%	30.37x	-	-	-	-	658B
ABBVIE INC.	2.59%	2.72%	33.76x	-370.52x	7.81x	16.23x	16.88x	467B
ROCHE HOLDING AG	2.7%	2.76%	20.64x	7.41x	4.89x	12.12x	13.44x	369B
NOVARTIS AG	2.76%	2.88%	22.46x	6.32x	5.78x	14.33x	15.28x	301B
ASTRAZENECA PLC	2.02%	2.16%	21.25x	4.75x	4.36x	12.44x	13.09x	256B
AMGEN INC.	2.27%	2.4%	28.07x	21.21x	7.23x	12.84x	16.59x	240B
NOVO NORDISK A/S	3.78%	3.75%	13.6x	5.65x	4.83x	10.09x	11.79x	207B
GILEAD SCIENCES, INC.	2.25%	2.31%	-44.84x	9.99x	6.47x	25.28x	61.91x	182B
PFIZER INC.	6.16%	6.21%	17.53x	1.82x	3.32x	8.48x	9.68x	159B
VERTEX PHARMACEUTICALS INCORPORATED	-.--%	-.--%	32.29x	6.18x	9.33x	21.09x	22x	139B
BRISTOL-MYERS SQUIBB COMPANY	3.76%	3.82%	11.99x	5.65x	3.33x	8.65x	9.38x	137B
SANOFI	5.43%	5.75%	12.48x	1.27x	2.21x	7.15x	7.98x	109B
GSK PLC	3.68%	3.96%	14.29x	4.62x	2.82x	8.34x	9.28x	103B
CHUGAI PHARMACEUTICAL CO., LTD.	1.95%	2.22%	22.67x	5.12x	7.62x	14.46x	15.18x	72.26B
TAKEDA PHARMACEUTICAL COMPANY LIMITED	3.52%	3.59%	47.17x	1.24x	2.81x	9.9x	29.62x	58.19B
BAYER AG	0.32%	1.09%	20.74x	1.69x	1.7x	8.03x	13.55x	55.58B
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	0.55%	0.61%	33.18x	4.54x	7.86x	26.7x	27.6x	45.78B
HALEON PLC	2.19%	2.42%	19.24x	1.93x	3.46x	12.92x	14.39x	44.44B
Average	2.55%	2.7%	20.65x	-14.37x	5.48x	14.17x	18.63x	235.79B
Weighted average by Cap.	2.15%	2.26%	24.62x	-32.25x	7.56x	17.08x	20.31x